Skip to main content

Advertisement

SpringerLink
Log in

A patient diagnosed with BRAF-mutated non-small cell lung cancer and hairy cell leukemia: at last, which entity is really carrying the BRAF mutation?

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig.1

References

  1. Capper D, Preusser M, Habel A, Sahm F, Ackermann U, Schindler G, Pusch S, Mechtersheimer G, Zentgraf H, von Deimling A (2011) Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody. Acta Neuropathol 122(1):11–19

    Article  CAS  PubMed  Google Scholar 

  2. Long GV, Wilmott JS, Capper D (2013) Immunohistochemistry is highly sensitive and specific for the detection of V600E BRAF mutation in melanoma. Am J Surg Pathol 37(1):61–65

    Article  PubMed  Google Scholar 

  3. Ilie M, Long E, Hofman V (2013) Diagnostic value of immunohistochemistry for the detection of the BRAFV600E mutation in primary lung adenocarcinoma Caucasian patients. Ann Oncol 24(3):742–748

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

All authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectious Diseases, Rheumatology, Oncologic Center, Paracelsus Medical University, Salzburg, Austria

    Konstantin Schlick, Marlene Troch, Gudrun Placher-Sorko, Viktoria Faber, Richard Greil & Georg Hopfinger

  2. Department of Pathology, Paracelsus Medical University Salzburg, Salzburg, Austria

    Daniel Neureiter

  3. Department of Internal Medicine I, Clinical Oncology and Comprehensive Cancer Center and Bone Marrow Transplantation, Vienna General Hospital (AKH), Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria

    Marlene Troch & Matthias Preusser

  4. Institute of Neurology, Medical University of Vienna, Vienna, Austria

    Anna Sophie Berghoff

Authors
  1. Konstantin Schlick
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marlene Troch
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gudrun Placher-Sorko
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Viktoria Faber
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Daniel Neureiter
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Anna Sophie Berghoff
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Matthias Preusser
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Richard Greil
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Georg Hopfinger
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marlene Troch.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Schlick, K., Troch, M., Placher-Sorko, G. et al. A patient diagnosed with BRAF-mutated non-small cell lung cancer and hairy cell leukemia: at last, which entity is really carrying the BRAF mutation?. Ann Hematol 94, 345–346 (2015). https://doi.org/10.1007/s00277-014-2162-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-014-2162-5

Keywords

Search

Navigation